Products
AI Benchmark
Mobile
Monthly visits
17.1K
Down26.5%MoMOct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Unlinked
No verified creators
Launched
5y ago
2021-11-17 · Est.

Traffic

Monthly visitsData through Oct 2026
Events3 changes

Marketing moves

Launches, search & content, referrals, promotions
  • New product launchLaunch

    Nov 17, 2021 · 5y agoWebsite

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Organic Search67%
  • Direct16%
  • Referrals12%
  • AI Assistants5%

Countries

  • South Korea98%
  • United States2%

Search

Domain authority —Domain registered 2021-11-17

KeywordMonthly volume
증권3,780
다올투자증권990
다올투자증권 mcp470
옵션 증거금 장중 계산170
신종자본증권 장단점160

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-11-04

Key pages

Weekly snapshots
Home
daolsecurities.com Snapshot 2026-11-17

Changes

  1. Nov 16 · Yesterday

    Homepage tagline changed to “주식투자를 시작하시나요?”Positioning

    다올투자증권→주식투자를 시작하시나요?

    At the time: 17.1K visits/mo2 concurrent moves
  2. Nov 14 · 3d ago

    Homepage tagline changed to “다올투자증권”Positioning

    처음 시작하는 투자, 간편하게 시작하세요!→다올투자증권

    At the time: 17.1K visits/mo2 concurrent moves
  3. Nov 14 · 4d ago

    Homepage tagline changed to “처음 시작하는 투자, 간편하게 시작하세요!”Positioning

    다올투자증권→처음 시작하는 투자, 간편하게 시작하세요!

    At the time: 17.1K visits/mo2 concurrent moves

Questions & evidence

How much website traffic does 다올투자증권 get?
Vaneform estimates 17.1K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is 다올투자증권 and what platforms does it support?
다올투자증권 is catalogued under Investing & Trading: 주식투자를 시작하시나요? Supported platforms: Mobile App.

Related products in this category

Finance / Investing & Trading

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.